| Dr Lorenzo F Munoz, MD | |
|
1725 W Harrison St, Suite 970, Chicago, IL 60612-3841 | |
| (312) 942-6644 | |
| Not Available |
| Full Name | Dr Lorenzo F Munoz |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 32 Years |
| Location | 1725 W Harrison St, Chicago, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225022759 | NPI | - | NPPES |
| 036-097984-1 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 036-097984-1 (Illinois) | Primary |
| 208000000X | Pediatrics | 036-097984 (Illinois) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rush University Medical Center | Chicago, IL | Hospital |
| Franciscan Health Olympia Fields & Chicago Heights | Olympia fields, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rush University Medical Center | 5496658874 | 1007 |
News Archive
Even though Marlene Klein was having trouble recognizing familiar faces and began to mistake her fingers for carrots as she chopped vegetables, she had no idea she was slowly losing her vision to a leading cause of blindness, age-related macular degeneration.
Aastrom Biosciences, Inc., a leading developer of expanded autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that an interim analysis of all 86 patients enrolled in the company's Phase 2b RESTORE-CLI clinical trial shows that the study achieved both its primary safety endpoint and primary efficacy endpoint of time to first occurrence of treatment failure.
The "perfect storm" for Fibromyalgia, CFS/ME, and fatigue in general is preparing to hit. A combination of poor nutrition, decreasing sleep, increasing stress and environmental toxins has created a human energy crisis of unprecedented proportions. Over the past 10 years, the incidence of Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FMS) has exploded by 400 to 1000 percent, as documented in five separate studies. The numbers for those with CFS in the U.S., previously estimated at 500,000, are now being re-tallied at closer to 1- 2.5 million. Previous estimates placed the number of Americans with FMS at 6 million. Studies worldwide suggest this has likely gone up in the last decade to ~ 12-24 million Americans! Meanwhile, ¼ of Americans suffer with chronic pain and most are fatigued.
Recent advances in gene therapy, stem cells and other promising applications are offering new hope for patients and helping orthopaedic surgeons provide state-of-the-art treatment for various frame-related conditions.
New research from Baylor College of Medicine scientists shows that a combination of deep brain stimulation (DBS) and exercise has potential benefits for treating ataxia, a rare genetic neurodegenerative disease characterized by progressive irreversible problems with movement.
› Verified 5 days ago
| Entity Name | Rush University Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093819542 PECOS PAC ID: 5496658874 Enrollment ID: O20040202000228 |
News Archive
Even though Marlene Klein was having trouble recognizing familiar faces and began to mistake her fingers for carrots as she chopped vegetables, she had no idea she was slowly losing her vision to a leading cause of blindness, age-related macular degeneration.
Aastrom Biosciences, Inc., a leading developer of expanded autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that an interim analysis of all 86 patients enrolled in the company's Phase 2b RESTORE-CLI clinical trial shows that the study achieved both its primary safety endpoint and primary efficacy endpoint of time to first occurrence of treatment failure.
The "perfect storm" for Fibromyalgia, CFS/ME, and fatigue in general is preparing to hit. A combination of poor nutrition, decreasing sleep, increasing stress and environmental toxins has created a human energy crisis of unprecedented proportions. Over the past 10 years, the incidence of Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FMS) has exploded by 400 to 1000 percent, as documented in five separate studies. The numbers for those with CFS in the U.S., previously estimated at 500,000, are now being re-tallied at closer to 1- 2.5 million. Previous estimates placed the number of Americans with FMS at 6 million. Studies worldwide suggest this has likely gone up in the last decade to ~ 12-24 million Americans! Meanwhile, ¼ of Americans suffer with chronic pain and most are fatigued.
Recent advances in gene therapy, stem cells and other promising applications are offering new hope for patients and helping orthopaedic surgeons provide state-of-the-art treatment for various frame-related conditions.
New research from Baylor College of Medicine scientists shows that a combination of deep brain stimulation (DBS) and exercise has potential benefits for treating ataxia, a rare genetic neurodegenerative disease characterized by progressive irreversible problems with movement.
› Verified 5 days ago
| Entity Name | University Neurosurgery |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154379485 PECOS PAC ID: 4486665759 Enrollment ID: O20060526000164 |
News Archive
Even though Marlene Klein was having trouble recognizing familiar faces and began to mistake her fingers for carrots as she chopped vegetables, she had no idea she was slowly losing her vision to a leading cause of blindness, age-related macular degeneration.
Aastrom Biosciences, Inc., a leading developer of expanded autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that an interim analysis of all 86 patients enrolled in the company's Phase 2b RESTORE-CLI clinical trial shows that the study achieved both its primary safety endpoint and primary efficacy endpoint of time to first occurrence of treatment failure.
The "perfect storm" for Fibromyalgia, CFS/ME, and fatigue in general is preparing to hit. A combination of poor nutrition, decreasing sleep, increasing stress and environmental toxins has created a human energy crisis of unprecedented proportions. Over the past 10 years, the incidence of Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FMS) has exploded by 400 to 1000 percent, as documented in five separate studies. The numbers for those with CFS in the U.S., previously estimated at 500,000, are now being re-tallied at closer to 1- 2.5 million. Previous estimates placed the number of Americans with FMS at 6 million. Studies worldwide suggest this has likely gone up in the last decade to ~ 12-24 million Americans! Meanwhile, ¼ of Americans suffer with chronic pain and most are fatigued.
Recent advances in gene therapy, stem cells and other promising applications are offering new hope for patients and helping orthopaedic surgeons provide state-of-the-art treatment for various frame-related conditions.
New research from Baylor College of Medicine scientists shows that a combination of deep brain stimulation (DBS) and exercise has potential benefits for treating ataxia, a rare genetic neurodegenerative disease characterized by progressive irreversible problems with movement.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lorenzo F Munoz, MD 1725 W Harrison St, Suite 970, Chicago, IL 60612-3841 Ph: (312) 942-6644 | Dr Lorenzo F Munoz, MD 1725 W Harrison St, Suite 970, Chicago, IL 60612-3841 Ph: (312) 942-6644 |
News Archive
Even though Marlene Klein was having trouble recognizing familiar faces and began to mistake her fingers for carrots as she chopped vegetables, she had no idea she was slowly losing her vision to a leading cause of blindness, age-related macular degeneration.
Aastrom Biosciences, Inc., a leading developer of expanded autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that an interim analysis of all 86 patients enrolled in the company's Phase 2b RESTORE-CLI clinical trial shows that the study achieved both its primary safety endpoint and primary efficacy endpoint of time to first occurrence of treatment failure.
The "perfect storm" for Fibromyalgia, CFS/ME, and fatigue in general is preparing to hit. A combination of poor nutrition, decreasing sleep, increasing stress and environmental toxins has created a human energy crisis of unprecedented proportions. Over the past 10 years, the incidence of Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FMS) has exploded by 400 to 1000 percent, as documented in five separate studies. The numbers for those with CFS in the U.S., previously estimated at 500,000, are now being re-tallied at closer to 1- 2.5 million. Previous estimates placed the number of Americans with FMS at 6 million. Studies worldwide suggest this has likely gone up in the last decade to ~ 12-24 million Americans! Meanwhile, ¼ of Americans suffer with chronic pain and most are fatigued.
Recent advances in gene therapy, stem cells and other promising applications are offering new hope for patients and helping orthopaedic surgeons provide state-of-the-art treatment for various frame-related conditions.
New research from Baylor College of Medicine scientists shows that a combination of deep brain stimulation (DBS) and exercise has potential benefits for treating ataxia, a rare genetic neurodegenerative disease characterized by progressive irreversible problems with movement.
› Verified 5 days ago
Peleg Horowitz, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 5841 S Maryland Ave, Chicago, IL 60637 Phone: 888-824-0200 | |
Stephen Ondra, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 680 N Lake Shore Dr, Suite 1000, Chicago, IL 60611 Phone: 312-695-9797 | |
Adam Mendel Sonabend Worthalter, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 675 N Saint Clair St Ste 21-100, Chicago, IL 60611 Phone: 312-695-0990 | |
Kazuki Sakakura, Neurological Surgery Medicare: Medicare Enrolled Practice Location: 600 S Paulina St, Chicago, IL 60612 Phone: 628-628-6309 | |
Gail L Rosseau, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 4501 N Winchester Ave, 2nd Fl, Chicago, IL 60640 Phone: 773-250-0500 Fax: 773-250-0497 | |
Dr. Ravi Nunna, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1650 W Harrison St Ste 466, Chicago, IL 60612 Phone: 312-942-5495 | |
Tord Alden, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 2300 N Childrens Plz, Chicago, IL 60614 Phone: 773-880-4000 Fax: 773-281-1576 |